Try our Advanced Search for more refined results
- Products
- Lexis Advance
- Law360 In-Depth
- Law360 UK
- Law360 Updates
- Law360 Podcasts
- Beta Tools
- Track docs
- Track attorneys
- Track judges
- Adv. Search & Platform Tools
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Rankings
- Data-Driven Lawyers
- Regional Powerhouses
- Law360's MVPs
- Glass Ceiling Report
- Global 20
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Site Menu
- Join the Law360 team
- Search legal jobs
- Learn more about Law360
- Read testimonials
- Contact Law360
- Sign up for our newsletters
- Site Map
- Help
Life Sciences
Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
July 14, 2020
11th Circ. Again Affirms Atty's Stock Fraud Conviction
The Eleventh Circuit has affirmed an attorney's fraud conviction for the second time, flatly rejecting his revived argument that the government violated his due process rights by allowing false testimony at trial in 2013.
-
July 14, 2020
Fla. High Court Orders More Arguments On Pot License Law
The Florida Supreme Court on Tuesday asked a would-be medical marijuana company and the state's Department of Health to return to court for a second round of oral arguments over whether the law governing the licensing process is an unconstitutional "special law."
-
July 14, 2020
States' Case To Be Bellwether In Generic Drug Price-Fix MDL
The Pennsylvania federal judge overseeing multidistrict litigation for price-fixing allegations in the generic drug industry has selected a case from state attorneys general to serve as a bellwether along with three private cases centered on individual drugs.
-
July 14, 2020
5th Circ. Upholds $905K Verdict In Diagnostic Lab Spat
The Fifth Circuit on Monday upheld a $905,000 verdict against a Texas lab testing company sued by a Louisiana lab testing company with whom it had formerly partnered, saying neither side had a solid argument for questioning the outcome.
-
July 14, 2020
How Cosmetics Cos. Can Prepare For Growth In Class Actions
Given light federal regulation of cosmetics, consumers are increasingly turning to class action litigation against the cosmetics industry, so companies should carefully review manufacturing processes and marketing claims, say attorneys at Perkins Coie.
Areas of Coverage
- AGENCIES
- U.S. Consumer Product Safety Commission
- U.S. Food and Drug Administration
- U.S. Patent and Trademark Office
- U.S. International Trade Commission
- POLICY & REGULATION
- Affordable Care Act
- Federal Food, Drug, and Cosmetic Act
- Antitrust and consumer protection controls
- Drug and medical device lobbying
- State and international life sciences legislation and regulation
- ENFORCEMENT
- Drug and medical device recalls
- Drug safety actions
- Pay-for-delay investigations
- Merger reviews
- LITIGATION
- Patent disputes, including
- Abbreviated New Drug Application litigation
- Section 301 cases
- Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
- Consumer litigation and class actions
- Fraud and compliance suits
- Antitrust disputes
- Labor and employment suits
- Shareholder and corporate governance disputes
- Bankruptcy proceedings
- TRANSACTIONS
- Mergers, acquisitions, and joint ventures
- Share buybacks and stock splits
- Private equity deals
- Patent-licensing agreements
- PROFILES
- Personnel moves
- Profiles of life sciences practice groups
Readership
- Life sciences lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the drug, biotechnology, and medical device industries
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals